It is further estimated that about 5%–10% of all breast cancer cases are attributable to a BRCA1/2 mutation [3], and women identified with a BRCA1/2 mutation face significantly increased lifetime risks of developing breast cancer [4,5]. The gene discussed is BRCA1; the disease is breast carcinoma.